| # | Title | Journal | Year | Citations |
|---|
| 1 | Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial | Lancet Oncology, The | 2018 | 110 |
| 2 | New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology and Oncology | 2020 | 79 |
| 3 | Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells | Journal of Experimental and Clinical Cancer Research | 2016 | 33 |
| 4 | Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure | Cancer Science | 2018 | 26 |
| 5 | Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma | Cancer Biology and Medicine | 2020 | 25 |
| 6 | R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms | Chinese Medical Journal | 2021 | 25 |
| 7 | Ruxolitinib‐combined doxorubicin‐etoposide‐methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single‐arm, multicentre, phase 2 trial | British Journal of Haematology | 2021 | 24 |
| 8 | The landscape of new drugs in extranodal NK/T-cell lymphoma | Cancer Treatment Reviews | 2020 | 20 |
| 9 | Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis | Haematologica | 2020 | 19 |
| 10 | All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial | Lancet Haematology,the | 2021 | 19 |
| 11 | A population study using the human erythrocyte PIG‐A assay | Environmental and Molecular Mutagenesis | 2016 | 17 |
| 12 | Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center | International Journal of Hematology | 2018 | 16 |
| 13 | LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma | Theranostics | 2021 | 16 |
| 14 | The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study | Cancer Biology and Medicine | 2021 | 15 |
| 15 | CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside | Blood | 2019 | 14 |
| 16 | Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia | Blood Cancer Journal | 2022 | 14 |
| 17 | Biomarkers for predicting the efficacy of immune checkpoint inhibitors | Journal of Cancer | 2022 | 12 |
| 18 | Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming | Molecular Cancer | 2022 | 12 |
| 19 | A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma | Clinical Cancer Research | 2020 | 11 |
| 20 | Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI | Acta Radiologica | 2016 | 10 |
| 21 | Is central obesity associated with diabetic retinopathy in Chinese individuals? An exploratory study | Journal of International Medical Research | 2019 | 10 |
| 22 | Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study | Oncologist | 2020 | 10 |
| 23 | Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis | Journal of Cancer Research and Clinical Oncology | 2021 | 10 |
| 24 | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups | Frontiers in Oncology | 2021 | 10 |
| 25 | All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP | Blood | 2021 | 10 |
| 26 | GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy | PLoS ONE | 2017 | 9 |
| 27 | An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment | Journal of Immunology Research | 2021 | 9 |
| 28 | The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation | Annals of Hematology | 2019 | 8 |
| 29 | Extranodal natural-killer T-cell lymphoma: experience from China | Lancet Haematology,the | 2020 | 8 |
| 30 | Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia | Aging | 2020 | 8 |
| 31 | Helicobacter pyloriinfection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study | Platelets | 2016 | 7 |
| 32 | A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study | British Journal of Cancer | 2021 | 7 |
| 33 | Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study | Platelets | 2015 | 6 |
| 34 | LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis | Cancer Biology and Therapy | 2021 | 6 |
| 35 | Targeting Bruton Tyrosine Kinase With Zanubrutinib for Treatment of Vitreoretinal Lymphoma: Report of 3 Cases | Frontiers in Oncology | 2021 | 6 |
| 36 | T Cell Epitope Screening of Epstein-Barr Virus Fusion Protein gB | Journal of Virology | 2021 | 5 |
| 37 | Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study | American Journal of Hematology | 2021 | 5 |
| 38 | Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis | Translational Cancer Research | 2021 | 5 |
| 39 | Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study | Therapeutic Advances in Hematology | 2022 | 5 |
| 40 | Targeting Bruton’s tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study | Experimental Hematology and Oncology | 2022 | 5 |
| 41 | Successful treatment of extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis with MEDA chemotherapy | Leukemia and Lymphoma | 2017 | 4 |
| 42 | Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | 2021 | 4 |
| 43 | Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma | International Journal of Biological Sciences | 2022 | 4 |
| 44 | Recombinant human thrombopoietin increases platelet count in severe thrombocytopenic patients with hepatitis B‐related cirrhosis: Multicentre real‐world observational study | Journal of Viral Hepatitis | 2022 | 4 |
| 45 | Single‐cell RNA sequencing infers the role of malignant cells in drug‐resistant multiple myeloma | Clinical and Translational Medicine | 2021 | 4 |
| 46 | Septicemia and pneumonia due to Mycobacterium fortuitum infection in a patient with extronodal NK/T-cell lymphoma, nasal type | Medicine (United States) | 2017 | 3 |
| 47 | PD-1 blockade in extranodal NK/T-cell lymphoma: who is in charge? | Leukemia | 2020 | 3 |
| 48 | Cladribine with Granulocyte Colony‐Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study | Oncologist | 2020 | 3 |
| 49 | New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma | Leukemia and Lymphoma | 2020 | 3 |
| 50 | Targeting Bruton Tyrosine Kinase for the Treatment of Vitreoretinal Lymphoma: Report of 11 Consecutive Patients | Blood | 2021 | 3 |
